Comparable Effectiveness of Weight-Based and Fixed-Dose Pembrolizumab in Non–Small Cell Lung Cancer: Insights From a National Real-World Cohort Among 189 study participants (mean age = 62.5 years, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results